
Captor Therapeutics Spolka Akcyjna
WSE:CTX.WA
Overview | Financials
Company Name | Captor Therapeutics Spolka Akcyjna |
Symbol | CTX.WA |
Currency | PLN |
Price | 105 |
Market Cap | 487,799,550 |
Dividend Yield | 0% |
52-week-range | 82 - 184 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Thomas Shepherd Ph.D. |
Website | https://www.captortherapeutics.com |
An error occurred while fetching data.
About Captor Therapeutics Spolka Akcyjna
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has five projects at the preclinical stage.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD